tiprankstipranks
LifeVantage Corp (LFVN)
NASDAQ:LFVN
US Market

LifeVantage (LFVN) Earnings Dates, Call Summary & Reports

Compare
182 Followers

Earnings Data

Report Date
May 01, 2025
TBA Not Confirmed
Period Ending
2025 (Q3)
Consensus EPS Forecast
0.16
Last Year’s EPS
0.21
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Feb 05, 2025
|
% Change Since: -26.61%
|
Next Earnings Date:May 01, 2025
Earnings Call Sentiment|Positive
The earnings call reflects a strong quarter for LifeVantage, driven by the successful launch and demand for the MindBody GLP-1 System, significant revenue growth, improved profitability metrics, and a solid cash position. However, challenges such as inventory constraints, a decline in certain international markets, and higher incentive expenses present notable challenges. The overall sentiment leans positive due to the outweighing highlights.
Company Guidance
During the second quarter of fiscal 2025, LifeVantage Corporation reported impressive financial metrics, driven by the success of their newly launched MindBody GLP-1 System. The company achieved a revenue of $67.8 million, marking a sequential growth of nearly 44% from the first quarter and a year-over-year increase of 31%. Gross margins improved by 190 basis points compared to the previous year, while adjusted EBITDA more than doubled to $6.5 million, representing 9.6% of revenue. The launch led to a significant increase in active accounts, particularly in the Americas, where they grew by 25% compared to Q1. Additionally, subscription metrics exceeded 70%, spurred by the MindBody System's long-term lifestyle benefits. The product demonstrated significant clinical results, including an average 140% increase in natural GLP-1 production, contributing to a reduction in visceral fat by up to 27% and total body fat by 5.5%. The company's strategic focus remains on sustaining growth, enhancing digital capabilities, and preparing for the international rollout of MindBody, with fiscal 2025 revenue guidance set between $235 million and $245 million.
Significant Revenue Growth
Revenue for the second quarter was $67.8 million, representing sequential growth of nearly 44% from the first quarter and year-over-year growth of 31%.
Successful Product Launch
The MindBody GLP-1 System was launched in October and sold out within 13 days. Additional inventory was received mid-December, clearing backlog by the end of December.
Improved Profitability Metrics
Gross margins increased by 190 basis points year-over-year, and adjusted EBITDA more than doubled to $6.5 million or 9.6% of revenue.
Increase in Active Accounts
Active accounts in the Americas increased by 23,000 or 25% compared to Q1, with a 13% increase in independent consultants and a 31% increase in customers.
Positive Clinical Results
The MindBody GLP-1 System led to a 140% increase in natural GLP-1 production, reducing visceral fat by up to 27% and total body fat by up to 5.5%.
Strong Cash Position
$21.6 million in cash and no debt at the end of the second quarter.
---

LifeVantage (LFVN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

LFVN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 01, 20252025 (Q3)
0.16 / -
0.21
Feb 05, 20252025 (Q2)
0.13 / 0.22
0.1120.00% (+0.12)
Oct 29, 20242025 (Q1)
0.15 / 0.15
0.1315.38% (+0.02)
Aug 28, 20242024 (Q4)
0.21 / 0.14
0.17-17.65% (-0.03)
May 02, 20242024 (Q3)
0.16 / 0.21
0.08162.50% (+0.13)
Jan 30, 20242024 (Q2)
0.04 / 0.10
-0.07242.86% (+0.17)
Nov 09, 20232024 (Q1)
- / 0.13
0.06116.67% (+0.07)
Aug 28, 20232023 (Q4)
- / 0.17
0.011600.00% (+0.16)
May 04, 20232023 (Q3)
- / 0.08
0.12-33.33% (-0.04)
Feb 02, 20232023 (Q2)
- / -0.07
0.036-294.44% (-0.11)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

LFVN Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 05, 2025$22.74$18.99-16.49%
Oct 29, 2024$12.94$12.89-0.39%
Aug 28, 2024$8.75$7.72-11.77%
May 02, 2024$6.04$6.49+7.45%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does LifeVantage Corp (LFVN) report earnings?
LifeVantage Corp (LFVN) is schdueled to report earning on May 01, 2025, TBA Not Confirmed.
    What is LifeVantage Corp (LFVN) earnings time?
    LifeVantage Corp (LFVN) earnings time is at May 01, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is LFVN EPS forecast?
          LFVN EPS forecast for the fiscal quarter 2025 (Q3) is 0.16.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis